These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6782615)

  • 21. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral effects of quipazine in the cat.
    Trulson ME; Brandstetter JW; Crisp T; Jacobs BL
    Eur J Pharmacol; 1982 Mar; 78(3):295-305. PubMed ID: 6461558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide.
    Gresch PJ; Barrett RJ; Sanders-Bush E; Smith RL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):662-9. PubMed ID: 17077317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behaviorally induced sensitivity to the discriminable properties of LSD.
    Greenberg I; Kuhn DM; Appel JB
    Psychopharmacologia; 1975 Sep; 43(3):229-32. PubMed ID: 1187955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The stimulus properties of LSD in C57BL/6 mice.
    Winter JC; Kieres AK; Zimmerman MD; Reissig CJ; Eckler JR; Ullrich T; Rice KC; Rabin RA; Richards JB
    Pharmacol Biochem Behav; 2005 Aug; 81(4):830-7. PubMed ID: 16005500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LDS-25 as a discriminative stimulus for response selection by pigeons.
    Järbe TU
    Pharmacol Biochem Behav; 1980 Oct; 13(4):549-54. PubMed ID: 6107936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the stimulus properties of barbital and hallucinogens.
    Hirschhorn ID; Winter JC
    Pharmacol Biochem Behav; 1975; 3(3):343-7. PubMed ID: 1153438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Training dose as a factor in LSD-saline discrimination.
    White FJ; Appel JB
    Psychopharmacology (Berl); 1982; 76(1):20-5. PubMed ID: 6805003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.
    White FJ; Appel JB
    Psychopharmacology (Berl); 1981; 73(2):110-5. PubMed ID: 6785800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminative stimulus properties of lysergic acid diethylamide in the monkey.
    Nielsen EB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):244-9. PubMed ID: 4009503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of quipazine on behavior under a multiple schedule of reinforcement.
    Poling A; Appel JB
    Pharmacol Biochem Behav; 1978 Apr; 8(4):491-2. PubMed ID: 674254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 Oct; 121(3):357-63. PubMed ID: 8584618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists.
    Grome JJ; Harper AM
    J Neurochem; 1986 Jan; 46(1):117-24. PubMed ID: 3940273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.
    Winter JC; Eckler JR; Rabin RA
    Psychopharmacology (Berl); 2004 Mar; 172(2):233-40. PubMed ID: 14598016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D; Thisted RA; Nichols DE
    Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generalization of morphine and lysergic acid diethylamide (LSD) stimulus properties to narcotic analgesics.
    Hirschhorn ID; Rosecrans JA
    Psychopharmacology (Berl); 1976 May; 47(1):65-9. PubMed ID: 8812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of quipazine and fluoxetine on extinction of a previously-reinforced operant response in rats.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 Oct; 21(4):533-7. PubMed ID: 6334317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.